Zhang Weitong, Wang Zhenfen, Cai Guohao, Huang Ping
Department of Anorectal Surgery, Hainan General Hospital, Haikou, Hainan, 570311, People's Republic of China.
Cancer Manag Res. 2021 Mar 23;13:2717-2731. doi: 10.2147/CMAR.S294880. eCollection 2021.
Chemoresistance is one key factor for the failure of cisplatin (CDDP)-based therapy in colorectal cancer (CRC). Although circular RNAs (circRNAs) are associated with chemoresistance development, the role and mechanism of hsa_circ_0071589 (circ_0071589) in the development of CDDP resistance in CRC remain unclear.
CDDP-resistant and sensitive CRC samples were collected. CDDP-resistant HCT116/CDDP and LOVO/CDDP cells were established. The levels of circ_0071589, microRNA (miR)-526b-3p and Krüppel-like factor 12 (KLF12) were detected via quantitative reverse transcription polymerase chain reaction, Western blot or immunohistochemistry. Cell viability, proliferation, cycle process, apoptosis, migration and invasion were examined via Cell Counting Kit-8, flow cytometry, transwell assay and Western blot. The association between miR-526b-3p and circ_0071589 or KLF12 was predicted by starBase, and explored via dual-luciferase reporter assay and RNA immunoprecipitation. The effect of circ_0071589 on CDDP resistance in CRC in vivo was investigated using a xenograft model.
Circ_0071589 level was upregulated in CDDP-resistant CRC tissue samples and cell lines. Circ_0071589 knockdown inhibited CDDP resistance, proliferation, migration and invasion, and promoted apoptosis in CDDP-resistant CRC cells. Circ_0071589 was a sponge for miR-526b-3p. MiR-526b-3p knockdown reversed the role of circ_0071589 inhibition in CDDP resistance. MiR-526b-3p suppressed CDDP resistance by directly targeting KLF12. Circ_0071589 regulated KLF12 expression through modulating miR-526b-3p. Circ_0071589 knockdown aggravated CDDP-induced reduction of xenograft tumor growth by upregulating miR-526b-3p and decreasing KLF12.
Knockdown of circ_0071589 repressed CDDP resistance in CDDP-resistant CRC cells by regulating the miR-526b-3p/KLF12 axis.
化疗耐药是基于顺铂(CDDP)的疗法在结直肠癌(CRC)治疗中失败的一个关键因素。尽管环状RNA(circRNA)与化疗耐药的发生有关,但hsa_circ_0071589(circ_0071589)在CRC顺铂耐药发生中的作用和机制仍不清楚。
收集顺铂耐药和敏感的CRC样本。建立顺铂耐药的HCT116/CDDP和LOVO/CDDP细胞系。通过定量逆转录聚合酶链反应、蛋白质印迹法或免疫组织化学检测circ_0071589、微小RNA(miR)-526b-3p和Krüppel样因子12(KLF12)的水平。通过细胞计数试剂盒-8、流式细胞术、Transwell实验和蛋白质印迹法检测细胞活力、增殖、细胞周期进程、凋亡、迁移和侵袭。通过starBase预测miR-526b-3p与circ_0071589或KLF12之间的关联,并通过双荧光素酶报告基因实验和RNA免疫沉淀进行探究。使用异种移植模型研究circ_0071589对CRC体内顺铂耐药的影响。
circ_0071589水平在顺铂耐药的CRC组织样本和细胞系中上调。敲低circ_0071589可抑制顺铂耐药的CRC细胞的顺铂耐药性、增殖、迁移和侵袭,并促进其凋亡。circ_0071589是miR-526b-3p的海绵。敲低miR-526b-3p可逆转circ_0071589抑制对顺铂耐药的作用。miR-526b-3p通过直接靶向KLF12抑制顺铂耐药。circ_0071589通过调节miR-526b-3p来调节KLF12的表达。敲低circ_0071589通过上调miR-526b-3p和降低KLF12来加重顺铂诱导的异种移植肿瘤生长的减少。
敲低circ_0071589通过调节miR-526b-3p/KLF12轴抑制顺铂耐药的CRC细胞中的顺铂耐药性。